NASDAQ:ENLV   Enlivex Therapeutics Ltd.
The mutations are rampant, the drug Allocetra™ Immune rebalancing for patients in critical condition is here ..... ENLV
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.